Results 101 to 110 of about 5,703,716 (143)

Salivary Metabolomics in Patients with Long COVID-19 Infection. [PDF]

Metabolites
Machado L, Prudente R, Franco E, Gatto M, Mota G, Pagan L, Brizola L, Dos Santos M, Cunha T, Sabino-Silva R, Goulart L, Martins M, Santos P, Maia L, Albuquerque A, Ferreira E, Baldi B, Okoshi M, Tanni S.   +18 more
europepmc   +1 more source

COF-PEI-PEG nanocarriers enhance dsRNA delivery to improve RNAi-based insect pest control. [PDF]

Pest Manag Sci
Chen Y, Deng M, Van Der Voort P, De Schutter K.   +3 more
europepmc   +1 more source

Graphene-based materials: an innovative approach for neural regeneration and spinal cord injury repair. [PDF]

RSC Adv
Yari-Ilkhchi A, Hamidi N, Mahkam M, Ebrahimi-Kalan A.   +3 more
europepmc   +1 more source

Vaccination-enabled immune readiness for checkpoint blockade. [PDF]

Front Immunol
Bautista J, López-Cortés A.
europepmc   +1 more source

Cancer vaccines: platforms and current progress. [PDF]

Mol Biomed
Lei W, Zhou K, Lei Y, Li Q, Zhu H.
europepmc   +1 more source

The advantages of NK cell vaccines in solid carcinoma clinical trials: conducted by various biology strategy and technology. [PDF]

Front Med (Lausanne)
Hu Y, Leng L, Li B, Qiao Q.
europepmc   +1 more source

Byron II luncheon menu

, 2012
Byron II (Restaurant)
core  

Cancer chemoprevention: signaling pathways and strategic approaches. [PDF]

Signal Transduct Target Ther
Ren J, Yan G, Yang L, Kong L, Guan Y, Sun H, Liu C, Liu L, Han Y, Wang X.   +9 more
europepmc   +1 more source

Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines. [PDF]

Vaccines (Basel)
Liang J, Liao Y, Tu Z, Liu J.
europepmc   +1 more source

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens. [PDF]

J Biomed Sci
Chi WY, Hu Y, Huang HC, Kuo HH, Lin SH, Kuo CJ, Tao J, Fan D, Huang YM, Wu AA, Hung CF, Wu TC.   +11 more
europepmc   +1 more source